Howard University / Presbyterian Hospital / Columbia University / Vancouver General Hospital / University of Chicago Cancer Research Center / Duke University / The University of Chicago / Ontario Cancer Institute / University of Michigan / Squier Urological Clinic / College of Physicians / University of California / University of Illinois at Chicago / University School / Harvard University / National Human Genome Center / University of California Davis Cancer Center / University of California San Francisco Cancer Center / Burnham Institute / University of Chicago / National Cancer Institute / Mayo Clinic / Edith Nourse Rogers Memorial Veterans Hospital / University of Medicine / Laboratory Medicine / Baylor College of Medicine / Houston Veterans Affairs Medical Center / Clinic Foundation / The Cancer Institute of New Jersey / /
IndustryTerm
prostate cancer therapies / treatment of prostate cancer / computer technology / Treatment of Hormone Refractory Prostate Cancer / chemical pathways / Treatment of Localized Prostate Cancer / Treatment for Advanced Prostate Cancer / Therapy for Prostate Cancer / treatment of human prostate cancer / chemical signaling pathways / Prostate Cancer Treatment / chemical factors / /
MedicalCondition
aggressive prostate cancers / aggressive prostate cancer / WILL end cancer / metastatic prostate cancer / disparate prostate cancer / large volume disease / widespread viral infection / older prostate cancer / prostate cancer / tumor / prostate tumor / cancer / clinically advanced disease / prostatic intraepithelial neoplasia / Award Mechanism Research Idea Development New Investigator Health Disparity Research-Prostate Scholar Awards Infrastructure Consortium Development Training/Recruitment Health Disparity Training-Prostate Scholar Awards Postdoctoral Traineeships Total disease / innovative prostate cancer / progressive prostate cancer / Localized Prostate Cancer / diseases / Radiorecurrent Prostate Cancer / early cancers / local prostate cancer / metastases / advanced disease / Metastasis / dormant prostate cancer / cold sores / herpes / Prostate Cancer Disparity While cancer / head and neck cancer / aggressive cancer / Against Cancer / cancers / advanced prostate cancer / disease / either benign tumors / clinically localized radiorecurrent prostate cancer / increased prostate cancer / commonly diagnosed cancer / high tumor / tumor necrosis / human prostate cancer / hormoneresistant prostate cancer / post-prostatectomy urinary incontinence / resistant cancer / Hormone Refractory Prostate Cancer / Disease Cancer / /
MedicalTreatment
Alternative Medicine / vaccination / surgery / radiation / prostatectomy / cancer therapies / radiation therapy / chemotherapy / hormone therapy / gene therapy / invasive surgery / /
Organization
Columbia University / University of California / National Human Genome Center / Genome Center / Cancer Center / University of Michigan / University of Illinois at Chicago / DOD PCRP / Houston Veterans Affairs Medical Center / Duke University / Edith Nourse Rogers Memorial Veterans Hospital / Baylor Prostate Center / Department of Laboratory Medicine / Mount Sinai School of Medicine / Baylor College of Medicine / University of Chicago / Robert Wood Johnson Medical School / Burnham Institute / American Cancer Society / American Urological Association / Cleveland Clinic Foundation / U.S. Army Medical Research and Materiel Command / College of Physicians and Surgeons / University of Medicine and Dentistry of New Jersey / Johns Hopkins School of Medicine / National Cancer Institute / University of California San Francisco Cancer Center / Harvard University / Harvard / New York University School of Medicine / Congress / Presbyterian Hospital / The University of Chicago / Vancouver General Hospital / Ontario Cancer Institute / Cancer Institute of New Jersey / office of Research / Department of Defense / Howard University / University of Chicago Cancer Research Center / /
Person
Ian Mohr / Ralph DeVere / Gustavo E. Ayala / Rick A. Kittles / Prostate Cancer Therapies Mitchell Sokoloff / Jeremy Squire / Ralph de Vere / Eugene Kwon / Vere White / Robert Dreicer / Kim Chi / Ronald Lieberman / Barbara TerryKoroma / Leo Giambarresi / Ronald Morton / Urologic Oncology / Frederic Waldman / Catherine Iola / Lorrie Powel / Gail S. Prins / Howard R. Soule / Fort Detrick / Eric Small / L. Freedman / Jack Clark / Carl Olsson / David Altshuler / Robert Wood Johnson / Virgil Simons / Monica Liebert / Dana Farber / Thomas E. Carey / Powell / Anning Lin / Marva Price / Robert DiPaola / Donald Coffey / Phillip Kantoff / Nicholas Vogelzang / Matthew L. Freedman / Winston Dyer / Simon Hall / Ralph DeVere White / / /
Position
Professor of Oncology / Professor of Pharmacology / Professor of Pathology / R.N. / Dr. P.H. / Professor and Chair / physician / Member of the Board of Directors / CapCURE / Chief Science Officer / CapCURE / Director / DNA Cytometry Service and Director / Chief / advocate / Professor of Urology / Professor of Oncology / Director / Laboratory / Professor / Professor and Chairman / Department of Urology / Director / Lank Center for Genitourinary Oncology / Director / Genitourinary Program / Integration Panel Chair / Associate Professor / Professor of Medicine / Investigator / Program Manager / Medical Director / Director / Prostate Cancer Program / Executive Vice-President and Chief Science Officer / Director of Laboratories / Director / Director of Urological Service / Professor of Physiology / Chair / Special Populations Program Manager / Professor of Pharmacology / Chief of Urology / /
Section IV Prostate Cancer Research Program Vision: To conquer prostate cancer.